A detailed history of Integrated Advisors Network LLC transactions in Dexcom Inc stock. As of the latest transaction made, Integrated Advisors Network LLC holds 1,785 shares of DXCM stock, worth $117,238. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,785
Previous 5,114 65.1%
Holding current value
$117,238
Previous $709,000 71.51%
% of portfolio
0.01%
Previous 0.04%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$110.31 - $140.45 $367,221 - $467,558
-3,329 Reduced 65.1%
1,785 $202,000
Q1 2024

May 03, 2024

SELL
$114.22 - $140.1 $74,243 - $91,065
-650 Reduced 11.28%
5,114 $709,000
Q4 2023

Feb 26, 2024

BUY
$75.49 - $124.16 $110,592 - $181,894
1,465 Added 34.08%
5,764 $715,000
Q3 2023

Nov 16, 2023

SELL
$86.06 - $137.93 $352,415 - $564,823
-4,095 Reduced 48.78%
4,299 $401,000
Q2 2023

Jul 14, 2023

BUY
$112.47 - $130.98 $451,004 - $525,229
4,010 Added 91.47%
8,394 $1.08 Million
Q1 2023

May 05, 2023

SELL
$104.0 - $122.92 $35,880 - $42,407
-345 Reduced 7.3%
4,384 $509,000
Q4 2022

Feb 02, 2023

BUY
$84.98 - $122.67 $401,870 - $580,106
4,729 New
4,729 $535,000
Q3 2022

Nov 07, 2022

BUY
$76.35 - $94.18 $73,219 - $90,318
959 Added 24.36%
4,896 $394,000
Q2 2022

Aug 12, 2022

BUY
$67.99 - $132.89 $202,338 - $395,480
2,976 Added 309.68%
3,937 $293,000
Q1 2022

May 02, 2022

BUY
$94.08 - $130.2 $21,073 - $29,164
224 Added 30.39%
961 $492,000
Q4 2021

Feb 14, 2022

SELL
$129.87 - $162.82 $519 - $651
-4 Reduced 0.54%
737 $396,000
Q3 2021

Nov 15, 2021

SELL
$106.71 - $143.18 $426 - $572
-4 Reduced 0.54%
741 $405,000
Q2 2021

Aug 06, 2021

BUY
$80.99 - $107.93 $2,267 - $3,022
28 Added 3.91%
745 $318,000
Q1 2021

May 17, 2021

BUY
$84.79 - $104.74 $5,680 - $7,017
67 Added 10.31%
717 $258,000
Q4 2020

Feb 12, 2021

BUY
$78.0 - $104.5 $50,700 - $67,925
650 New
650 $240,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $25.4B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Integrated Advisors Network LLC Portfolio

Follow Integrated Advisors Network LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Integrated Advisors Network LLC, based on Form 13F filings with the SEC.

News

Stay updated on Integrated Advisors Network LLC with notifications on news.